Alabama files lawsuit against opioid manufacturer

February 6, 2018 by Kim Chandler

Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

Alabama Attorney General Alabama Steve Marshall filed the lawsuit in Montgomery federal court against Purdue Pharma, L.P. and its branches. The lawsuit claims the manufacturer created a deceptive marketing campaign that misled patients about the benefits of the drugs and the risks of addiction.

"The opioid epidemic has devastated Alabama families, leaving a trail of addiction and death winding through every community of this state," Marshall said in a statement.

"It will take years to undo the damage but an important first step we must take is to hold the parties responsible for this epidemic legally liable for the destruction they have unleashed upon our citizens."

Marshall said he anticipates the lawsuit will eventually be transferred to Ohio where multi-district litigation is ongoing. The Alabama attorney general attended the start of settlement talks in that litigation last week.

At least 13 states have filed lawsuits against opioid manufacturers.

Alabama ranks first in the nation in the number of painkiller prescriptions per capita. Alabama had more than 5.8 million opioid prescriptions written in 2015. That equates to a rate of 1.2 prescriptions per person, the highest rate in the country. By comparison, the national per capita was 0.71 in 2015.

Marshall's office estimated that 30,000 Alabamians over age 17 are dependent upon heroin and prescription painkillers.

John Puskar, director of public affairs for Purdue Pharma L.P., said the company vigorously denies the allegations in the state's lawsuit.

"We are deeply troubled by the prescription and illicit opioid abuse crisis, and are dedicated to being part of the solution. As a company grounded in science, we must balance patient access to FDA-approved medicines, while working collaboratively to solve this public health challenge," Puskar said in a statement.

He said the company has distributed the Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain, developed three of the first four FDA-approved opioid medications with abuse-deterrent properties and partnered with law enforcement to ensure access to naloxone, a drug that reverses overdoses.

Explore further: South Carolina sues drug manufacturer over opioid crisis

Related Stories

South Carolina sues drug manufacturer over opioid crisis

August 15, 2017
South Carolina has become the latest state to accuse a drug manufacturer of exacerbating its opioid drug crisis by using deceptive marketing, with the state's top prosecutor suing the maker of OxyContin.

Philadelphia sues opioid makers in response to epidemic

January 17, 2018
Philadelphia has filed a lawsuit against drug companies that make prescription opioids, saying they've created "an unprecedented public health crisis."

New York hits big pharma with $500mn lawsuit in opioid crisis

January 23, 2018
New York turned the screws on pharmaceutical giants in America's opioid epidemic, suing manufacturers for $500 million on Tuesday as a photographer kickstarted a petition to hold Purdue Pharma accountable as a recovering ...

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

3 Native American tribes sue opioid industry groups

January 9, 2018
Three Native American tribes in the Dakotas are suing opioid manufacturers and distributors, alleging they concealed and minimized the addiction risk of prescription drugs.

Washington state, Seattle are latest to sue opioid makers

September 28, 2017
Washington state and the city of Seattle on Thursday joined more than two dozen other government entities across the country suing to hold opioid makers accountable for an addiction crisis that has claimed thousands of lives.

Recommended for you

Common use of antipsychotics shown ineffective for delirium in intensive care patients

October 22, 2018
Critically ill patients in intensive care units (ICUs) did not benefit from two antipsychotic drugs used to treat delirium, according to a large clinical trial funded by the National Institute on Aging, part of the National ...

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.